An advisory panel to the Food and Drug Administration voted against a similar request from Pfizer in mid-September, but the agency is considered likely to grant the request, perhaps before Thanksgiving. By Sharon LaFraniere from NYT U.S…. Read more.
Pfizer and BioNTech are expected to ask federal regulators to authorize their boosters for all adults.
An advisory panel to the Food and Drug Administration voted against a similar request from Pfizer in mid-September, but the agency is considered likely to grant the request, perhaps before Thanksgiving. By Sharon LaFraniere from NYT U.S…. Read more.